Top Markets
#1 Cortex Cortex +173.85%
#2 GEKKO GEKKO +52.86%
#3 Audiera Audiera +20.07%
#4 ADO Protocol ADO Protocol +17.27%
#5 Seeker Seeker +16.11%
#6 o1.exchange o1.exchange +12.87%
#7 Status Status +9.82%
#8 OpenGradient OpenGradient +9.53%
#9 Pons Pons +9.24%
#10 Helium Helium +8.90%
Coin of the day
Cortex Cortex
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Clasificación en acciones #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Precio por acción
$59.98
Última sincronización: 2024-12-13
Capitalización bursátil
$1.22B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Longboard Pharmaceuticals, Inc. (LBPH)

Categoría

Healthcare
Ratio P/S de Longboard Pharmaceuticals, Inc. (LBPH)
Ratio P/S al August 2026 TTM: 0.00
Según los informes financieros más recientes y el precio de las acciones de Longboard Pharmaceuticals, Inc., el ratio P/S actual (TTM) es 0.00. Al final de 2022, el ratio P/S era 0.00.
Historial del ratio P/S de Longboard Pharmaceuticals, Inc. desde 2020 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH